Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Although many medications exist for both heart disease and obesity, cost, lack of access for all people, side effects and the desire for a more natural solution have left many people seeking lifestyle treatments such as exercise. Scientists know that exercise is highly beneficial for heart health. When exercise also produces weight loss, these benefits are much improved. Although using exercise to treat or prevent heart disease / obesity is recommended, not all people respond well. Some see significant weight loss and health improvements while others see little changes. For these reasons, new strategies surrounding the use and design of an exercise program are needed. One such strategy could be performing aerobic exercise before breakfast (fasted exercise). When exercising fasted, food/energy stores are low, and one relies on stored body fat for energy. This may help heart health and weight loss. This has never been tested in a program long enough to see such changes. This study will, for the first time, assess the effects of a 16-week aerobic exercise program performed fasted compared to after eating. Outcomes will include blood fats, blood pressure, fat-burning abilities and weight loss.
Starting an exercise program can also make people to eat more. This limits the success of exercise. The study will also evaluate ways fasted exercise could change eating, as it possible that fasted exercise could also cause people to eat more, which would limit weight loss and health improvements.
This study will be the first to evaluate a long-term (16-week) aerobic exercise intervention performed in the fasted state (compared to fed state) at a guidelines-based dose. Primary outcomes for Aim 1 will include changes in fat & fat-free mass (DXA), energy compensation, blood pressure & lipids, aerobic fitness, and substrate oxidation (respiratory quotient, RQ) at rest and during activity.
It is also important to understand sources of response variability to an exercise program. Individuals tend to compensate for the energy they expend during exercise, primarily by increasing energy intake (EI). Such compensatory eating behaviors likely stem from a series of evolutionarily conserved responses, ensuring energy is available for vital organ function and reproduction when faced with an energy deficit. This proposal will be the first to evaluate how fasted exercise training influences (Aim 2 outcomes): physiological hunger (hormonal responses to a standardized meal) and behavioral constructs shown to influence EI and weight status (food reinforcement and attentional bias towards food cues). The overall hypothesis is that fasted state exercise will result in greater energy compensation, attenuating weight loss compared to an identical dose of exercise performed in the post-prandial state. This study will further hypothesize an attenuated weight loss with fasted exercise training will negate beneficial cardiovascular adaptations stemming from improvements in oxidative metabolism commonly associated with fasted exercise. Adults (aged 18-59 years, BMI: 25-45 kg/m2) will be randomized to a 16-week supervised aerobic exercise intervention (progressing to a guidelines-based dose of 1600 kcal/wk). Exercise sessions will be performed between 0500h and 1100h, 4 days per week in either the fasted state (FAST, 8-12 hour fast) or post-prandially (FED, within 3 hours of eating at least 300 kcal).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fasted group | Experimental | Complete all exercise sessions of intervention before breakfast- fasted at least 8 hours |
|
| Fed exercise group | Experimental | Complete all exercise sessions of intervention after breakfast- within 3 hours of eating at least 300 kcal |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 16 week exercise intervention | Behavioral | Both groups will receive a 16-week supervised aerobic exercise program progressing to 1,600 kcal of EE per wk (4 sessions/week) at moderate intensity (40-50% heart rate reserve, HRR). |
| Measure | Description | Time Frame |
|---|---|---|
| body composition | kg of fat free and fat mass via DXA | Baseline (week 0) and post-intervention (week 25) |
| Measure | Description | Time Frame |
|---|---|---|
| Total and acylated ghrelin | Total and acylated ghrelin (pg/mL in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal. | Baseline (week 0) and post-intervention (week 25) |
| GLP-1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kyle D Flack, PhD | Contact | (479) 434-4019 | kyle.flack@achehealth.edu | |
| Blake Metcalf, DCN | Contact | 479-434-4003 | blake.metcalf@achehealth.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Arkansas Colleges of Health Education Research Institure Health and Wellness Center | Recruiting | Fort Smith | Arkansas | 72916 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D009043 | Motor Activity |
| D015431 | Weight Loss |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
2 group trial, 1:1 allocation, Fed exercise group (complete all exercise sessions of the intervention within 3 hrs of eating) vs. Fasted exercise group (complete all exercise sessions of the intervention in fasted state)
Not provided
Not provided
Cannot blind groups
Not provided
Glucagon-like peptide 1 (GLP-1, Pmol/L in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal. |
| Baseline (week 0) and post-intervention (week 25) |
| PYY | Peptide YY (PYY, pmol/L plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal. | Baseline (week 0) and post-intervention (week 25) |
| Leptin | Leptin (ng/mL in plasma) will be assessed in the fasted state and response to a test meal via blood sampling at 0 minutes (pre meal), 15, 30, 45, 60, 90, and 120 minutes post-meal. | Baseline (week 0) and post-intervention (week 25) |
| Food reinforcement | amount of work one is willing to do for a snack food | Baseline (week 0) and post-intervention (week 25) |
| Attentional bias for food cues | percentage of time fixated on food cues during a dot-probe task, assessed by eye tracking | Baseline (week 0) and post-intervention (week 25) |
| Skeletal muscle efficiency | kcal expended per kg per watt during a graded cycle ergometer test | Baseline (week 0) and post-intervention (week 25) |
| walking ecconomy | Gross energetic cost of movement (J/kg/m) will be assessed during a graded walking test with indirect calorimetry. | Baseline (week 0) and post-intervention (week 25) |
| resting metabolic rate | Resting metabolic rate assessed via indirect calorimetry | Baseline (week 0) and post-intervention (week 25) |
| muscle strength | Peak torque and work per repetition (Foot-Pounds) will be assessed during an isokinetic and isometric task | Baseline (week 0) and post-intervention (week 25) |
| muscle power | Average power (watts) will be assessed during an isokinetic and isometric task | Baseline (week 0) and post-intervention (week 25) |
| skeletal muscle mass | The D3Cr dilution technique will be used to determine kg of skeletal muscle mass | Baseline (week 0) and post-intervention (week 25) |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001519 | Behavior |
| D001836 | Body Weight Changes |